Charity C. Fox MD

PubMed

• Successful use of rifampin in a patient with Stevens-Johnson syndrome to rifabutin.
  Jennifer R. Yonkof, David E. Tapke, Charity C. Fox, Princess U. Ogbogu
  Annals of Allergy, Asthma & Immunology. 2020-03-10
• 71 citations
  AAAAI Mast Cell Disorders Committee Work Group Report: Mast Cell Activation Syndrome (MCAS) Diagnosis and Management
  Catherine R. Weiler, K. Frank Austen, Cem Akin, Marla S. Barkoff, Jonathan A. Bernstein
  The Journal of Allergy and Clinical Immunology. 2019-10-01
• 8 citations
  Treatment of adult hyper-IgD syndrome with canakinumab.
  Casey Curtis, Charity C. Fox
  The Journal of Allergy and Clinical Immunology. in Practice. 2015-09-01

Journal Articles

• Treatment of Adult Hyper-IgD Syndrome with Canakinumab  
  Curtis, CR and Fox, C.C., J Allergy Clin Immunol Pract, 1/1/2015
• A 42-year-old man with fever, shock, and rash  
  Rahmanian SD, Molenda M, Fox C, Zirwas M, Sood N, Chest, 1/1/2010
• The CD4+ Lymphopenic Sarcoidosis Phenotype is Highly Responsive to Anti-TNF-(alpha) Therapy  
  Crouser E, Lozanski G, Fox C, Hauswirth D, Raveendran R, Julian M, Chest, 1/1/2010

Books/Book Chapters

• Human Inflammatory Disease: Clinical Immunology Vol. I. 
  Chapter: In vitro and in vivo studies of human basophils and mast cells: Mediators, secretagogues and pharmacology. 
  Page 39 - 47Kagey-Sobotka A., MacDonald SM, Fox C, Warner JA and Lichtenstein LMEditors: Marone, Lichtenstein, Condorelli, Fauci.B.C. Decker, Toronto, Canada; Philadelphia, PA1988
• Inflammatory Bowel Disease: current status and future approach. Proceedings of the International Symposium on Future Research Approaches to Inflammatory Bowel Disease. 
  Chapter: Enhanced Intestinal Mast Cell Histamine Release in Idiopathic Inflammatory Bowel Disease. 
  Page 355 - 359Fox CC, Moore WC, Bayless TM and Lichtenstein LMEditors: R.P. MacDermott.Excerpta Medica, Amsterdam, The Netherlands1988
• Mast Cell Differentiation and Heterogeneity. 
  Chapter: Heterogeneity in human histamine containing cells. 
  Page 331 - 345Lichtenstein LM, Fox CC, Schleimer RP, Proud D, Naclerio RM and Kagey-Sobotka AEditors: J Bienenstock, AD Befus, and JA Denburg.Raven Press, New York, NY1986

Abstracts/Posters

• Treatment of Adult Hyper-IgD Syndrome with Canakinumab.
  Curtis, CR and Fox CC, Ann Allergy Asthma Immunol, 1/1/2013
• Adult Presentation of Hyper IgD Syndrome: Fevers and IgG subclass deficiency.
  Raveendran R and Fox C, Ann Allergy Asthma Immunol, 1/1/2011
• Adalimumab-induced angioedema in a young woman with Crohns Disease.
  Cho CB, Patterson AM, Fox, CC, Ogbogu PU, Ann Allergy Asthma Immunol, 1/1/2010

Lectures

• Update on Mast Cell Activation Syndrome 
  Ohio State University - 1/25/2019
• Mast Cell Activation Syndrome: Navigating the Information Maze with Your Patient 
  San Francisco, CA - 1/22/2019
• Angioedema 
  Ohio State University - 1/26/2018

Other

• Recent Advances in the Treatment of Allergies. 
  Fox CC, Ohio Medical Education Network, OMEN TV and Radio
  1/21/2000
• Recent Advances in Allergy. Daily radio presentation and live TV presentation. 
  Fox CC, Ohio Medical Education Network, OMEN TV and Radio
  1/22/1999
• Indications and Use of Steroids in Allergy and Immunology. Daily radio presentation and live TV presentation. 
  Fox CC, Ohio Medical Education Network, OMEN TV and Radio
  1/24/1994